Short-term clinical outcome of stroke patients with or without prior statin treatment

Document Type : Original Article

Authors

1 Students Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

2 Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

3 Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Objective(s): This study evaluated the impact of statin on the severity and outcome of stroke among patients who had taken it prior to the stroke onset and compared to patients who had not received it before the stroke.

Methods: We included 261 consecutive patients with acute ischemic stroke who admitted in Namazee hospital affiliated to Shiraz University of Medical Sciences from 2018-2019. We recorded demographic data, vascular risk factors, history of previous statin treatment, and National Institutes of Health Stroke Scale (NIHSS) score at time of hospital admission and modified Rankin Scale (MRS) 3 months after stroke onset. The dependent variables were initial severity of stroke as measured by National Institute of Health Scoring System (NIHSS) and good outcome defined as modified Rankin Scale (MRS) 0 to 1.

Results: Among 261 patients with acute ischemic stroke, 76 were using statins (52.6% of users were women). Among all the subjects, 175 (67.6%) had history of hypertension, 78 (30.1%) had history of diabetes mellitus, 87(33.5%) had history of hyperlipidemia, 63 (24.3%) were smokers. Admission NIHSS and MRS were not statistically different in statin users and non-statin users (P= 0.12 and P= 0.08, respectively). Adjusted Odds Ratios for poor functional outcome and 90-day mortality according to previous statin use were 0.87 (95% CI 0.37-2.05), P= 0.54) and 0.75(95% CI 0.31-1.81, P= 0.52) which were not statistically significant.

Conclusion: This study showed that pre-stroke statin therapy did not affect the initial clinical severity, short-term functional outcome and 90-day mortality after ischemic stroke.

Keywords

References


1. Borhani-Haghighi A, Safari R, Heydari ST, et al. Hospital mortality associated with stroke in southern iran. Iran J Med Sci. 2013;38(4):314-320.
2. Shahtaheri RA, Borhani Haghighi A, Safari A, Cruz-Flores S. Recombinant tissue plasminogen activator (rtPA) and stroke unit for acute ischaemic stroke in developing countries, are they cost-effective? Int J Stroke. 2012 Oct;7(7):E9. doi: 10.1111/j.1747-4949.2012.00892.x. PMID: 22989402.
3. Romero JR, Morris J, Pikula A. Stroke prevention: modifying risk factors. Ther Adv Cardiovasc Dis. 2008;2(4):287-303. doi:10.1177/1753944708093847
4. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Jul;45(7):2160-236. doi: 10.1161/STR.0000000000000024. Epub 2014 May 1. Erratum in: Stroke. 2015 Feb;46(2):e54. PMID: 24788967.
5. Li Q, Zhuang QK, Yang JN, Zhang YY. Statins excert neuroprotection on cerebral ischemia independent of their lipid-lowering action: the potential molecular mechanisms. Eur Rev Med Pharmacol Sci. 2014;18(8):1113-26. PMID: 24817284.
6. Nasoohi S, Simani L, Khodagholi F, Nikseresht S, Faizi M, Naderi N. Coenzyme Q10 supplementation improves acute outcomes of stroke in rats pretreated with atorvastatin. Nutr Neurosci. 2019 Apr;22(4):264-272. doi: 10.1080/1028415X.2017.1376928. Epub 2017 Sep 26. PMID: 28946820.
7. Choi JC, Lee JS, Park TH, Cho YJ, Park JM, Kang K, et al. Effect of pre-stroke statin use on stroke severity and early functional recovery: a retrospective cohort study. BMC Neurol. 2015 Jul 30;15:120. doi: 10.1186/s12883-015-0376-3. PMID: 26224123; PMCID: PMC4520077.
8. Cordenier A, De Smedt A, Brouns R, Uyttenboogaart M, De Raedt S, Luijckx GJ, De Keyser J. Pre-stroke use of statins on stroke outcome: a meta-analysis of observational studies. Acta Neurol Belg. 2011 Dec;111(4):261-7. PMID: 22368964.
9. Ní Chróinín D, Asplund K, Åsberg S, Callaly E, Cuadrado-Godia E, Díez-Tejedor E, et al. Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke. 2013 Feb;44(2):448-56. doi: 10.1161/STROKEAHA.112.668277. Epub 2013 Jan 3. PMID: 23287777.
10. Arboix A, García-Eroles L, Oliveres M, Targa C, Balcells M, Massons J. Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia? BMC Neurol. 2010 Jun 18;10:47. doi: 10.1186/1471-2377-10-47. PMID: 20565890; PMCID: PMC2905355.
11. Hong KS, Lee JS. Statins in Acute Ischemic Stroke: A Systematic Review.
J Stroke. 2015;17(3):282-301. doi:10.5853/jos.2015.17.3.282
12. Elkind MS, Flint AC, Sciacca RR, Sacco RL. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology. 2005 Jul 26;65(2):253-8. doi: 10.1212/01.wnl.0000171746.63844.6a. PMID: 16043795.
13. Martí-Fàbregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvís R, Cocho D, Roquer J, Rodríguez A, García MD, Molina-Porcel L, Díaz-Manera J, Martí-Vilalta JL. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke. 2004 May;35(5):1117-21. doi: 10.1161/01.STR.0000125863.93921.3f. Epub 2004 Apr 8. PMID: 15073403.
14. Miedema I, Uyttenboogaart M, Koopman K, De Keyser J, Luijckx GJ. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke. Cerebrovasc Dis. 2010 Feb;29(3):263-7. doi: 10.1159/000275500. Epub 2010 Jan 15. PMID: 20090317.
15. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke. 2005 Jun;36(6):1298-300. doi: 10.1161/01.STR.0000165920.67784.58. Epub 2005 May 5. PMID: 15879346.
16. Ishikawa H, Wakisaka Y, Matsuo R, Makihara N, Hata J, Kuroda J, Ago T, Kitayama J, Nakane H, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators. Influence of Statin Pretreatment on Initial Neurological Severity and Short-Term Functional Outcome in Acute Ischemic Stroke Patients: The Fukuoka Stroke Registry. Cerebrovasc Dis. 2016;42(5-6):395-403. doi: 10.1159/000447718. Epub 2016 Jul 5. PMID: 27376661.
17. Tsivgoulis G, Katsanos AH, Sharma VK, et al. Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke. Neurology. 2016;86(12):1103-1111. doi:10.1212/WNL.0000000000002493
18. Alonzo C, Zurru M, Brescacin L, Campos VR, Camera L, Waisman G, et al. Neuroprotective Effect of Pre-Stroke Statin Therapy in a Cohort of Elderly Ischemic Stroke Patients (P03. 195). AAN Enterprises; 2013;195:P03.
19. Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA. 1998 May 27;279(20):1643-50. doi: 10.1001/jama.279.20.1643. PMID: 9613915.
20. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, Zhang C, Lu M, Katakowski M, Feldkamp CS, Chopp M. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol. 2003 Jun;53(6):743-51. doi: 10.1002/ana.10555. Erratum in: Ann Neurol. 2005 Nov;58(5):818. PMID: 12783420.
21. Nicholas JS, Swearingen CJ, Thomas JC, Rumboldt Z, Tumminello P, Patel SJ. The effect of statin pretreatment on infarct volume in ischemic stroke. Neuroepidemiology. 2008;31(1):48-56. doi: 10.1159/000140095. Epub 2008 Jun 18. PMID: 18560243.
22. Hillen T, Coshall C, Tilling K, Rudd AG, McGovern R, Wolfe CD; South London Stroke Register. Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register. Stroke. 2003 Jun;34(6):1457-63. doi: 10.1161/01.STR.0000072985.24967.7F. Epub 2003 May 15. PMID: 12750544.
Trends in Pharmaceutical Sciences
Volume 7, Issue 1
March 2021
Pages 27-34

Files

Share

How to cite

Statistics